Global Pharmaceutical Outlook and Implications of GLP-1 Drugs

Virtual Event

Click to register for the on-demand.
Click to register for the on-demand.

This webinar will discuss Moody’s Ratings’ outlook for the global pharmaceutical industry over the next 12-18 months and key performance drivers. Among other positive trends, the pharmaceutical industry is benefiting from the rising use of GLP-1 drugs to treat obesity. The webinar will also discuss the potential impact of GLP-1 drugs on other industries.

  • Positive outlook drivers for the global pharmaceutical industry
  • Rising use of industry blockbusters including GLP-1 products
  • Exposure to patent cliffs, quality of industry pipeline and rising use of biosimilars
  • M&A activities and expectations
  • Impact of GLP-1s on other sectors including medical devices, food/beverage and restaurants
  • Speakers keyboard_arrow_down
    image
    Ola Hannoun-Costa Associate Managing Director Moody’s Ratings Bio
    image
    Michael Levesque Senior Vice President Moody's Ratings Bio
    image
    Marie Fischer-Sabatié Senior Vice President Moody's Ratings Bio
    image
    Linda Montag Senior Vice President Moody's Ratings Bio
    image
    Michael Weinstein VP-Senior Analyst Moody’s Ratings Bio
    image
    Michael Zuccaro Vice President - Senior Analyst Moody’s Investors Service Bio
  • Event Manager keyboard_arrow_down

    If you have any questions about the event, please contact Morgan Prokhin at morgan.prokhin@moodys.com.